class name | count |
---|---|
rosids | 13 |
eudicotyledons | 5 |
Liliopsida | 4 |
asterids | 4 |
Magnoliophyta | 3 |
Euphyllophyta | 1 |
Spermatophyta | 1 |
class name | count |
---|---|
Fabaceae
![]() |
5 |
Paeoniaceae
![]() |
4 |
Brassicaceae
![]() |
4 |
Enterobacteriaceae
![]() |
2 |
Asteraceae
![]() |
2 |
Micrococcaceae
![]() |
2 |
Annonaceae
![]() |
2 |
Dennstaedtiaceae
![]() |
1 |
Petiveriaceae
![]() |
1 |
Rutaceae
![]() |
1 |
Posidoniaceae
![]() |
1 |
Apocynaceae
![]() |
1 |
Taxaceae
![]() |
1 |
Araceae
![]() |
1 |
Begoniaceae
![]() |
1 |
Malvaceae
![]() |
1 |
Salicaceae
![]() |
1 |
Boraginaceae
![]() |
1 |
Lauraceae
![]() |
1 |
Asparagaceae
![]() |
1 |
br08003 Category | # of metabolite |
---|
br08003 Category | KEGG ID | KNApSAcK ID |
---|
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
figure |
---|---|---|---|---|---|---|
C00000207
![]() |
Benzoic acid
|
CHEMBL541
|
D019817
|
97 / 39 / 33 | 24 / 1 |
![]() |
C00001401
![]() |
p-Aminobenzoic acid
|
CHEMBL542
|
D010129
|
9 / 10 / 10 | 4 / 1 |
![]() |
C00007382
![]() |
Anthranilic acid
|
CHEMBL14173
|
C031385
|
6 / 4 / 4 | 6 / 4 |
![]() |
C00007557
![]() |
o-Hydroxylaminobenzoate
|
![]() |
||||
C00017912
![]() |
2,4-Diaminobenzoic acid
/ 4-Aminoanthranilic acid |
C056333
|
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P16473 | Thyrotropin receptor | Glycohormone receptor | C00000207 C00001401 | 3 / 2 |
P80404 | 4-aminobutyrate aminotransferase, mitochondrial | Transferase | C00001401 C00007382 | 1 / 1 |
Q9UQ49 | Sialidase-3 | Enzyme | C00000207 C00001401 | 0 / 0 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00000207 | 0 / 0 |
Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00000207 | 2 / 2 |
P08246 | Neutrophil elastase | S1A | C00000207 | 2 / 1 |
P33765 | Adenosine receptor A3 | Adenosine receptor | C00000207 | 0 / 0 |
Q16539 | Mitogen-activated protein kinase 14 | p38 | C00000207 | 0 / 0 |
P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00000207 | 0 / 0 |
P29466 | Caspase-1 | C14 | C00000207 | 0 / 0 |
P17252 | Protein kinase C alpha type | Alpha | C00000207 | 0 / 0 |
P27361 | Mitogen-activated protein kinase 3 | Erk | C00000207 | 0 / 0 |
P14780 | Matrix metalloproteinase-9 | M10A | C00000207 | 2 / 2 |
Q99489 | D-aspartate oxidase | Enzyme | C00000207 | 0 / 0 |
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00000207 | 1 / 0 |
P51649 | Succinate-semialdehyde dehydrogenase, mitochondrial | Oxidoreductase | C00001401 | 1 / 1 |
P00918 | Carbonic anhydrase 2 | Lyase | C00000207 | 1 / 2 |
P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00000207 | 0 / 1 |
P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00000207 | 1 / 1 |
P25021 | Histamine H2 receptor | Histamine receptor | C00000207 | 0 / 0 |
P35367 | Histamine H1 receptor | Histamine receptor | C00000207 | 0 / 0 |
Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00000207 | 1 / 0 |
P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00000207 | 0 / 0 |
P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00000207 | 0 / 0 |
P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00000207 | 0 / 0 |
P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00000207 | 0 / 0 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | C00000207 | 0 / 0 |
P06241 | Tyrosine-protein kinase Fyn | Src | C00000207 | 0 / 0 |
Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00000207 | 0 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00000207 | 0 / 1 |
P14920 | D-amino-acid oxidase | Enzyme | C00000207 | 0 / 0 |
P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00000207 | 1 / 8 |
P14416 | D(2) dopamine receptor | Dopamine receptor | C00000207 | 2 / 0 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00000207 | 0 / 0 |
P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00000207 | 0 / 0 |
P41145 | Kappa-type opioid receptor | Opioid receptor | C00000207 | 0 / 0 |
Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00000207 | 0 / 0 |
P29274 | Adenosine receptor A2a | Adenosine receptor | C00000207 | 0 / 0 |
P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00000207 | 0 / 0 |
P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00000207 | 1 / 1 |
P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00000207 | 0 / 0 |
P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00000207 | 1 / 0 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00007382 | 0 / 0 |
P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00000207 | 0 / 0 |
O75496 | Geminin | Unclassified protein | C00001401 | 0 / 0 |
O60656 | UDP-glucuronosyltransferase 1-9 | Enzyme | C00000207 | 0 / 0 |
P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00000207 | 0 / 0 |
P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00000207 | 0 / 0 |
P21917 | D(4) dopamine receptor | Dopamine receptor | C00000207 | 0 / 0 |
P30988 | Calcitonin receptor | Calcitonin receptor | C00000207 | 0 / 0 |
P35462 | D(3) dopamine receptor | Dopamine receptor | C00000207 | 1 / 0 |
P41143 | Delta-type opioid receptor | Opioid receptor | C00000207 | 0 / 0 |
Q92731 | Estrogen receptor beta | NR3A2 | C00000207 | 0 / 1 |
P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00000207 | 0 / 0 |
P25101 | Endothelin-1 receptor | Endothelin receptor | C00000207 | 0 / 0 |
P30411 | B2 bradykinin receptor | Bradykinin receptor | C00000207 | 0 / 0 |
P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00000207 | 1 / 0 |
P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00000207 | 0 / 0 |
P08311 | Cathepsin G | S1A | C00000207 | 0 / 0 |
Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00000207 | 1 / 0 |
P03956 | Interstitial collagenase | M10A | C00000207 | 0 / 1 |
P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00000207 | 0 / 0 |
Q9GZT4 | Serine racemase | Enzyme | C00000207 | 0 / 0 |
P11308 | Transcriptional regulator ERG | Unclassified protein | C00001401 | 1 / 2 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | C00001401 | 0 / 0 |
P04150 | Glucocorticoid receptor | NR3C1 | C00000207 | 0 / 1 |
P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00000207 | 2 / 0 |
P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00000207 | 0 / 0 |
P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00000207 | 0 / 0 |
P31645 | Sodium-dependent serotonin transporter | Serotonin | C00000207 | 2 / 0 |
O94956 | Solute carrier organic anion transporter family member 2B1 | Unclassified protein | C00000207 | 0 / 0 |
P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00000207 | 5 / 9 |
P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00000207 | 1 / 0 |
P21452 | Substance-K receptor | Neurokinin receptor | C00000207 | 0 / 0 |
P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00000207 | 0 / 0 |
P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00000207 | 3 / 0 |
P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00000207 | 0 / 0 |
Q96RI1 | Bile acid receptor | NR1H4 | C00007382 | 0 / 0 |
P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00000207 | 1 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | C00000207 | 0 / 0 |
P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00000207 | 2 / 1 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00000207 | 0 / 3 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00007382 | 3 / 3 |
P51449 | Nuclear receptor ROR-gamma | Nuclear hormone receptor subfamily 1 group F member 3 | C00007382 | 0 / 0 |
O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00000207 | 0 / 0 |
P03372 | Estrogen receptor | NR3A1 | C00000207 | 1 / 1 |
P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00000207 | 1 / 0 |
P22303 | Acetylcholinesterase | Hydrolase | C00000207 | 1 / 0 |
P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00000207 | 0 / 0 |
P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00000207 | 0 / 0 |
P35372 | Mu-type opioid receptor | Opioid receptor | C00000207 | 0 / 0 |
P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00000207 | 0 / 0 |
P25103 | Substance-P receptor | Neurokinin receptor | C00000207 | 0 / 0 |
P25105 | Platelet-activating factor receptor | PAF receptor | C00000207 | 0 / 0 |
P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00000207 | 0 / 0 |
P51580 | Thiopurine S-methyltransferase | Enzyme | C00001401 | 1 / 1 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00000207 | 1 / 1 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00000207 | 0 / 1 |
P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00000207 | 0 / 0 |
P19224 | UDP-glucuronosyltransferase 1-6 | Enzyme | C00000207 | 0 / 0 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00007382 | 0 / 0 |
P10275 | Androgen receptor | NR3C4 | C00001401 | 3 / 4 |
P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00000207 | 1 / 1 |
P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00000207 | 0 / 0 |
P30542 | Adenosine receptor A1 | Adenosine receptor | C00000207 | 0 / 0 |
P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00000207 | 0 / 0 |
P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00000207 | 1 / 1 |
P06239 | Tyrosine-protein kinase Lck | Src | C00000207 | 0 / 1 |
P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00000207 | 0 / 0 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
1645 | AKR1C1, 2-ALPHA-HSD, 20-ALPHA-HSD, C9, DD1, DD1/DD2, DDH, DDH1, H-37, HAKRC, HBAB, MBAB | aldo-keto reductase family 1, member C1 (EC:1.3.1.20 1.1.1.149 1.1.1.112) |
C00000207
C00007382
|
2729 | GCLC, GCL, GCS, GLCL, GLCLC | glutamate-cysteine ligase, catalytic subunit (EC:6.3.2.2) |
C00000207
|
3592 | IL12A, CLMF, IL-12A, NFSK, NKSF1, P35 | interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) |
C00007382
|
3593 | IL12B, CLMF, CLMF2, IL-12B, NKSF, NKSF2 | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) |
C00007382
|
3606 | IL18, IGIF, IL-18, IL-1g, IL1F4 | interleukin 18 (interferon-gamma-inducing factor) |
C00007382
|
5604 | MAP2K1, CFC3, MAPKK1, MEK1, MKK1, PRKMK1 | mitogen-activated protein kinase kinase 1 (EC:2.7.12.2) |
C00007382
|
1385 | CREB1, CREB | cAMP responsive element binding protein 1 |
C00001401
|
9 | NAT1, AAC1, MNAT, NAT-1, NATI | N-acetyltransferase 1 (arylamine N-acetyltransferase) (EC:2.3.1.5) |
C00001401
|
4790 | NFKB1, EBP-1, KBF1, NF-kB1, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, NFkappaB, p105, p50 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
C00001401
|
7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00001401
|
231 | AKR1B1, ADR, ALDR1, ALR2, AR | aldo-keto reductase family 1, member B1 (aldose reductase) (EC:1.1.1.21) |
C00000207
|
57016 | AKR1B10, AKR1B11, AKR1B12, ALDRLn, ARL-1, ARL1, HIS, HSI | aldo-keto reductase family 1, member B10 (aldose reductase) (EC:1.1.1.2) |
C00000207
|
8644 | AKR1C3, DD3, DDX, HA1753, HAKRB, HAKRe, HSD17B5, PGFS, hluPGFS | aldo-keto reductase family 1, member C3 (EC:1.3.1.20 1.1.1.188 1.1.1.239 1.1.1.64 1.1.1.112 1.1.1.357) |
C00000207
|
2235 | FECH, EPP, FCE | ferrochelatase (EC:4.99.1.1) |
C00000207
|
2512 | FTL, NBIA3 | ferritin, light polypeptide |
C00000207
|
2539 | G6PD, G6PD1 | glucose-6-phosphate dehydrogenase (EC:1.1.1.49) |
C00000207
|
3458 | IFNG, IFG, IFI | interferon, gamma |
C00007382
|
2730 | GCLM, GLCLR | glutamate-cysteine ligase, modifier subunit (EC:6.3.2.2) |
C00000207
|
2936 | GSR | glutathione reductase (EC:1.8.1.7) |
C00000207
|
2938 | GSTA1, GST2, GSTA1-1, GTH1 | glutathione S-transferase alpha 1 (EC:2.5.1.18) |
C00000207
|
3162 | HMOX1, HMOX1D, HO-1, HSP32, bK286B10 | heme oxygenase (decycling) 1 (EC:1.14.99.3) |
C00000207
|
4097 | MAFG, hMAF | v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog G |
C00000207
|
4199 | ME1, HUMNDME, MES | malic enzyme 1, NADP(+)-dependent, cytosolic (EC:1.1.1.40) |
C00000207
|
4489 | MT1A, MT1, MT1S, MTC | metallothionein 1A |
C00000207
|
4502 | MT2A, MT2 | metallothionein 2A |
C00000207
|
4846 | NOS3, ECNOS, eNOS | nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) |
C00000207
|
1728 | NQO1, DHQU, DIA4, DTD, NMOR1, NMORI, QR1 | NAD(P)H dehydrogenase, quinone 1 (EC:1.6.5.2) |
C00000207
|
5226 | PGD, 6PGD | phosphogluconate dehydrogenase (EC:1.1.1.44) |
C00000207
|
22949 | PTGR1, LTB4DH, PGR1, ZADH3 | prostaglandin reductase 1 (EC:1.3.1.48 1.3.1.74) |
C00000207
|
6566 | SLC16A1, HHF7, MCT, MCT1 | solute carrier family 16 (monocarboxylate transporter), member 1 |
C00000207
|
140809 | SRXN1, C20orf139, Npn3, SRX, SRX1 | sulfiredoxin 1 (EC:1.8.98.2) |
C00000207
|
7295 | TXN, TRDX, TRX, TRX1 | thioredoxin |
C00000207
|
7296 | TXNRD1, GRIM-12, TR, TR1, TRXR1, TXNR | thioredoxin reductase 1 (EC:1.8.1.9) |
C00000207
|
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
#103780 | Alcohol dependence |
P08172
P14416 P31645 |
#614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
#300068 | Androgen insensitivity syndrome; ais |
P10275
|
#312300 | Androgen insensitivity, partial; pais |
P10275
|
#602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
#300615 | Brunner syndrome |
P21397
|
#162800 | Cyclic neutropenia |
P08246
|
#612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#615363 | Estrogen resistance; estrr |
P03372
|
#612219 | Ewing sarcoma; es |
P11308
|
#613163 | Gaba-transaminase deficiency |
P80404
|
#613659 | Gastric cancer |
P04626
|
#137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
#231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
#137800 | Glioma susceptibility 1; glm1 |
P04626
|
#609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#603932 | Intervertebral disc disease; idd |
P14780
|
#613688 | Long qt syndrome 2; lqt2 |
Q12809
|
#211980 | Lung cancer |
P00533
P04626 |
#608516 | Major depressive disorder; mdd |
P08172
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
%300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
#126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
#159900 | Myoclonic dystonia |
P14416
|
#202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
#601665 | Obesity |
P32245
|
#164230 | Obsessive-compulsive disorder; ocd |
P31645
|
#604715 | Orthostatic intolerance |
P23975
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#167000 | Ovarian cancer |
P04626
|
#613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
#607276 | Resting heart rate, variation in |
P08588
|
#608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
#609620 | Short qt syndrome 1; sqt1 |
Q12809
|
#313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 |
P10275
|
#271980 | Succinic semialdehyde dehydrogenase deficiency; ssadhd |
P51649
|
#610460 | Thiopurine s-methyltransferase deficiency |
P51580
|
#190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
#610379 | West nile virus, susceptibility to |
P51681
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | name | UniProt |
---|---|---|
H00016 | Oral cancer |
P00533
(related)
P00533 (marker) |
H00017 | Esophageal cancer |
P00533
(related)
P35354 (related) |
H00018 | Gastric cancer |
P00533
(related)
P04626 (related) |
H00022 | Bladder cancer |
P00533
(related)
P04626 (related) |
H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) |
H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
H00042 | Glioma |
P00533
(related)
P00533 (marker) |
H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) |
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) Q92731 (marker) |
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
H00019 | Pancreatic cancer |
P04626
(related)
|
H00027 | Ovarian cancer |
P04626
(related)
|
H00031 | Breast cancer |
P04626
(related)
P04626 (marker) |
H00046 | Cholangiocarcinoma |
P04626
(related)
P35354 (related) |
H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
H00079 | Asthma |
P07550
(related)
|
H00100 | Neutropenic disorders |
P08246
(related)
|
H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
H00036 | Osteosarcoma |
P08684
(marker)
|
H00024 | Prostate cancer |
P10275
(related)
P11308 (related) |
H00062 | Spinal and bulbar muscular atrophy (SBMA) |
P10275
(related)
|
H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) |
P10275
(related)
|
H00609 | 46,XY disorders of sex development (Other) |
P10275
(related)
|
H00035 | Ewing's sarcoma |
P11308
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00025 | Penile cancer |
P14780
(related)
P35354 (related) |
H00479 | Metaphyseal dysplasias |
P14780
(related)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H00548 | Brunner syndrome |
P21397
(related)
|
H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
Q99714 (related) |
H00964 | Thiopurine S-methyltransferase deficiency (TPMT deficiency) |
P51580
(related)
|
H00835 | Succinic semialdehyde dehydrogenase (SSADH) deficiency |
P51649
(related)
|
H01257 | GABA-transaminase deficiency |
P80404
(related)
|
H00720 | Long QT syndrome |
Q12809
(related)
|
H00725 | Short QT syndrome |
Q12809
(related)
|
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D019970 | Cocaine-Related Disorders |
C00007382
|
D008114 | Liver Neoplasms, Experimental |
C00007382
|
D010024 | Osteoporosis |
C00007382
|
D011297 | Prenatal Exposure Delayed Effects |
C00007382
|
D017453 | Dermatitis, Irritant |
C00001401
|
D003877 | Dermatitis, Contact |
C00000207
|